Turnover: 40.6 million EUR (2018)

Country: France

Diagast has been producing and marketing immunohematology reagents and systems for blood typing for 30 years. Diagast has an R&D center that offers breakthrough innovations, such as EM Technology in 2004 and M-Trap in 2012. Diagast also has a wide range of FDA-approved fermenters, which gives it a large production capacity.

Financial Data

DUNS: 343445375

Legal Name: DIAGAST

Address: 251 AV EUGENE AVINEE EURASANTE PARC, 59120 LOOS

Number of employees: Entre 200 et 249 salariés (2018)

Capital: 4 742 140 EUR


Financial Data:

Year Turnover (€) Net Profit (€) Fiscal Year End Fiscal Year Duration
2018 40 650 400 EUR 2 391 044 EUR 31/12/2018 12
2017 35 778 014 EUR 2 366 541 EUR 31/12/2017 12
2016 35 733 320 EUR 2 193 907 EUR 31/12/2016 12
2015 32 898 858 EUR 1 836 107 EUR 31/12/2015 12

Company Managers:

Position First Name Last Name Age Linkedin
Président Bruno MORINO 61

Studies mentioning this company

The in vitro diagnostics market - France

Other companies mentioned: